Guo Zhiyong, graduated from the Shandong Medical University, China in 1982. Member of Cardiovascular Surgery Specialist Committee of Chinese Physician Association. Vice chairman of heart failure committee in Shandong Physician Association. Working In cardiovascular surgery for over 30 years, specialized in performing heart double valve replacement, CABG, atrioventricular canal malformation correction surgery, Blaloclk 's and Bentall s' operation, total aortic arch replacement operation etc.. In 2009, pioneering cardiopulmonary exercise test of cardiac rehabilitation in China. From 2011 to 2014, Dr.Guo chaired the Chinese Heart Congress, CEPT and Rehabilitation Forum. Invited speaker of Great Wall International Cardiology Conference from 2011 to 2014.

Mr. Laliberte graduated as an RT in 1992 from College Rosemont, worked as anesthesia tech at the Montreal Children's Hospital 1992-1997, graduated from The Michener Institute in 1999, worked as pediatric perfusionist from 1999-2006 at the Montreal Children's Hospital, presently at the Montreal Heart Institute since 2006. He is both Canadian (CSCP) and American (ABCP) certified. Mr. Eric Laliberte went to China with Dr. Shum-Tim in 2010, 2011, 2012, 2014. They together did numerous cardiac operations to train local surgeons. He is actively involved in perfusion education and training in China besides the charity works.

Dr. Ren-Ke Li, MD, PhD is a Professor of Medicine in the Department of Surgery, Division of Cardiac Surgery and a Senior Scientist at the Toronto General Research Institute, University Health Network working in the field of stem cell transplantation and tissue engineering. Dr. Li completed his M.D. at Harbin Medical University in China and his M.Sc. and Ph.D. in Clinical Biochemistry at the University of Toronto. He became an Assistant Professor at the University of Toronto in 1993 and was promoted to Full Professor in 2002. He is the recipient of the Canada Research Chair in Cardiac Regeneration (Tier 1) of the Canadian Institutes of Health Research and was a Career Investigator of the Heart and Stroke Foundation of Canada. I was elected as a Fellow of the Canadian Academy of Health Sciences in 2011. Dr. Li has been on the forefront in the field of cell transplantation and tissue engineering. In 1996, he published the first demonstration that cells transplanted into myocardial scar tissue survived, differentiated into muscle tissue, and improved heart function. More recently, his group has defined optimal cell types for transplantation, and described the optimal conditions under which the transplanted cells can achieve the most efficient repair. Currently, his research group is attempting to determine the mechanisms by which transplanted cells exert their beneficial effects. Clarifying these mechanisms will allow them to develop the “next generation” of gene-enhanced cells for transplantation (cell-based gene therapy). Dr. Li has published 200 peer-reviewed papers and his work has appeared in high impact journals. He has been invited to contribute several commentaries and viewpoint articles and is an international opinion leader in his field.